Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaia Pocobelli

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Preventive Medicine|November 11, 2021
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristicsJennifer S Haas, David Cheng, Liyang Yu, et al.
Psycho-Oncology|February 1, 2019
Use of antidepressants after colon cancer diagnosis and risk of recurrenceGaia Pocobelli, Onchee Yu, Rebecca A Ziebell, et al.
Preventive Medicine Reports|June 17, 2024
Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systemsVeronica M Boratyn, Gaia Pocobelli, Steven J Atlas, et al.
Cancer Causes & Control : CCC|November 1, 2019
Changes in use of opioid therapy after colon cancer diagnosis: a population-based studyLu Chen, Jessica Chubak, Onchee Yu, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|June 25, 2021
Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014Gaia Pocobelli, Sascha Dublin, Jennifer F Bobb, et al.
Journal of the National Cancer Institute|February 16, 2026
Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screeningGaia Pocobelli, Natalie J Del Vecchio, Kara Cushing-Haugen, et al.
Annals of Internal Medicine|November 12, 2024
Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational StudyTheodore R Levin, Christopher D Jensen, Natalia Udaltsova, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
American Journal of Epidemiology|April 23, 2025
Neural tube defect risk in relation to opioid analgesic exposure during early pregnancyDenise M Boudreau, Gaia Pocobelli, Jennifer F Bobb, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Preventive Medicine|November 11, 2021
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristicsJennifer S Haas, David Cheng, Liyang Yu, et al.
Psycho-Oncology|February 1, 2019
Use of antidepressants after colon cancer diagnosis and risk of recurrenceGaia Pocobelli, Onchee Yu, Rebecca A Ziebell, et al.
Preventive Medicine Reports|June 17, 2024
Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systemsVeronica M Boratyn, Gaia Pocobelli, Steven J Atlas, et al.
Cancer Causes & Control : CCC|November 1, 2019
Changes in use of opioid therapy after colon cancer diagnosis: a population-based studyLu Chen, Jessica Chubak, Onchee Yu, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness StudiesMayura U Shinde, Katherine Shapiro, Laura Hou, et al.
Pharmacoepidemiology and Drug Safety|June 25, 2021
Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014Gaia Pocobelli, Sascha Dublin, Jennifer F Bobb, et al.
Journal of the National Cancer Institute|February 16, 2026
Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screeningGaia Pocobelli, Natalie J Del Vecchio, Kara Cushing-Haugen, et al.
Annals of Internal Medicine|November 12, 2024
Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years : An Observational StudyTheodore R Levin, Christopher D Jensen, Natalia Udaltsova, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
American Journal of Epidemiology|April 23, 2025
Neural tube defect risk in relation to opioid analgesic exposure during early pregnancyDenise M Boudreau, Gaia Pocobelli, Jennifer F Bobb, et al.
Pageof 5